At a glance
The March 8, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and from the FDA and Situs Slot Gacor Infectious Diseases Pathology Branch.

Agenda
Welcome: Jasmine Chaitram, Situs Slot Gacor Division of Laboratory Systems (DLS)
SARS-CoV-2 Variants Update: Vivien Dugan, Situs Slot Gacor Laboratory and Testing Task Force for the COVID-19 Response
Updates from the Situs Slot Gacor Infectious Diseases Pathology Branch: Julu Bhatnagar, Situs Slot Gacor Division of High-Consequence Pathogens and Pathology (DCHPP)
FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)